| 000 | 01651 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516060022.0 | ||
| 264 | 0 | _c20120215 | |
| 008 | 201202s 0 0 eng d | ||
| 022 | _a1349-7235 | ||
| 024 | 7 |
_a10.2169/internalmedicine.50.5320 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhong, Wen-Wen | |
| 245 | 0 | 0 |
_aMechanisms of genistein protection on pancreas cell damage in high glucose condition. _h[electronic resource] |
| 260 |
_bInternal medicine (Tokyo, Japan) _c2011 |
||
| 300 |
_a2129-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDNA Primers _xgenetics |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xetiology |
| 650 | 0 | 4 |
_aEstradiol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEstrogen Antagonists _xpharmacology |
| 650 | 0 | 4 | _aFulvestrant |
| 650 | 0 | 4 | _aGenes, bcl-2 |
| 650 | 0 | 4 |
_aGenistein _xpharmacology |
| 650 | 0 | 4 |
_aGlucose _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin-Secreting Cells _xdrug effects |
| 650 | 0 | 4 |
_aPhytoestrogens _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xgenetics |
| 700 | 1 | _aLiu, Yang | |
| 700 | 1 | _aLi, Chun-Lin | |
| 773 | 0 |
_tInternal medicine (Tokyo, Japan) _gvol. 50 _gno. 19 _gp. 2129-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2169/internalmedicine.50.5320 _zAvailable from publisher's website |
| 999 |
_c21200182 _d21200182 |
||